Waddill William D.

Waddill William D. is listed in filings as Director at Protagonist Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including sale activity. Recent filings connect the profile to Protagonist Therapeutics, Inc. (PTGX), Arrowhead Pharmaceuticals Inc (ARWR), and Annexon, Inc. (ANNX). The current snapshot covers public activity from Dec 18, 2024 to Jun 25, 2026. Reported amounts are shown as $1.1M to $969.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.